IP Library › Granted Patent US 10,369,179
Granted Patent B2
US 10,369,179 · App. 14/852,604 · Granted Aug 6, 2019

Composition of

Inventor: Kodimule Shyam Prasad (Bangalore, IN)
Assignee: Vidya Herbs, Inc.
A61K36/22A61K9/0053A61K31/353A61K31/7048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,179
App. No.
14/852,604
Granted
Aug 6, 2019
Kind
B2
Abstract

The invention relates to a herbal composition derived from Mangifera indica . Methods of making and using the composition for the management of obesity are also contemplated.

Claims (22)

1. A composition comprising:

about 22% mangiferin,

about 4% catechin,

about 3% epicatechin

about 0.4% quercetin dihydrate,

4.5+/−0.42% gallic acid;

0.93+/−0.23% 3,4 dihydroxy benzoic acid;

1.2+/−0.34% methyl gallate;

2.31+/−0.73% propyl gallate;

0.48+/−0.08% pyrogallol;

1.43+/−0.07% parahydroxy benzoic acid;

0.33+/−0.06% vanillic acid;

0.82+/−0.13% syringic acid;

0.12+/−0.02% ferulic acid;

0.76+/−0.14% ethyl gallate; and

0.16+/−0.05% ellagic acid;

wherein said composition has a total flavonoid content of about 29% and a total polyphenol content of about 19%, and

wherein said composition is in an administration form selected from the group consisting of: a pill, tablet, capsule, lozenge, chewing gum, emulsion, topical patch, buccal patch, and gummy.

2. The composition of claim 1 , wherein said composition further comprises an excipient.

3. The composition of claim 1 , wherein said composition further comprises a sweetener, aromatic, flavoring, or combinations thereof.

4. The composition of claim 1 , wherein said composition further comprises a mineral, protein, amino acid, carbohydrate, or combinations thereof.

5. The composition of claim 1 , wherein said composition inhibits lipase activity by about 52% at a concentration of about 100 μg/ml in vitro.

Continuity (1)
Related Publication 20170071993A1 · Mar 16, 2017
Cited By (1)
US 12,226,443